Enliven Therapeutics, Inc. · NASDAQ:ELVN
BlackRock, Inc. reported a 5.10% stake in Enliven Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 5.10% stake in Enliven Therapeutics, Inc., 2,941,395 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G/A).
- Stake
- 5.10%
- Shares
- 2,941,395
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.10% | 2,941,395 |